Jeffrey Tyner, Ph.D., and Melissa Stewart, Ph.D., led a team at OHSU that discovered a new drug combination that may help people with acute myeloid leukemia. (OHSU/Christine Torres Hicks)

Jeffrey Tyner, Ph.D., and Melissa Stewart, Ph.D., led a team at OHSU that discovered a new drug combination that may help people with acute myeloid leukemia. (OHSU/Christine Torres Hicks)

Jared Fischer, Ph.D., left, and Jose Luis Montoya Mira, Ph.D., cancer researchers at OHSU, have developed PAC-MANN, a test that uses a small blood sample to detect changes in protease activity, a key indicator of the most common and deadliest form of pancreatic cancer. (OHSU/Christine Torres Hicks)

Li Xiang, Ph.D., postdoctoral scholar at the OHSU Knight Cancer Institute, and Michael Henderson, B.A., biomedical engineering Ph.D. student, are part of a team that developed a new nanoparticle that makes cancer treatment safer and more effective. (OHSU/Christine Torres Hicks)

OHSU patient and employee Ariel Shaak holds her daughter, Makenna. She said she is thankful to have a family of her own after a difficult cancer journey. (OHSU/Christine Torres Hicks)

Jared Fischer, Ph.D., a la izquierda, y Jose Luis Montoya Mira, Ph.D., investigadores de cáncer en OHSU, han desarrollado PAC-MANN, una prueba que utiliza una pequeña muestra de sangre para detectar cambios en la actividad de las proteasas, un indicador clave de la forma más común y mortal de cáncer de páncreas. (OHSU/Christine Torres Hicks)